Novo Nordisk Research Center Gladsaxe ApS — Credit Rating and Financial Key Figures

Novo Nordisk Research Center Gladsaxe ApS (CVR number: 39119374) is a company from GLADSAXE. The company recorded a gross profit of -38 kDKK in 2024. The operating profit was -76 kDKK, while net earnings were 6174 kDKK. The profitability of the company measured by Return on Assets (ROA) was 3 %, which can be considered weak and Return on Equity (ROE) was 3 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 79.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Novo Nordisk Research Center Gladsaxe ApS's liquidity measured by quick ratio was 4.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.